Thyrocare Technologies Limited has announced that its Board of Directors approved an amendment to the company’s Code of Conduct to Regulate, Monitor, and Report Trading by Designated Persons and their Immediate Relatives, also known as the “PIT Code.” The amended PIT Code, aimed at regulating insider trading, is now accessible on the company’s website. The approval occurred at a board meeting held on January 28, 2026.
Amended Code of Conduct
The Board of Directors of Thyrocare Technologies Limited has officially approved an amendment to its Code of Conduct designed to regulate trading activities by designated individuals. This amendment, approved on January 28, 2026, refines guidelines for designated persons and their immediate relatives. This action underscores the company’s dedication to upholding the principles of fair practice and regulatory standards in securities trading.
Key Details of the Amendment
The primary focus of this amendment centers on the “PIT Code,” intended to govern and monitor trading conduct. It covers designated persons and their immediate relatives. The updated code is now publicly available for review on the company’s investor relations website, providing stakeholders with detailed insights into the amended regulations.
Source: BSE
